An Experienced Team
Founded by top-tier scientists, our talented team is also backed by a skilled board of directors and advised by a range of medical experts from several backgrounds enabling us to tap into their well of knowledge to broaden and refine our patented technologies.
Cutting Edge Technology
Our patented technology combined with trade secrets positions VisionGate with unique competitive advantage in the marketplace. We are able to accurately detect lung cancer at an early stage with a simple, non-intrusive test.
With a 20 times increase in high risk patient cases and $20 billion dollar potential, our patented technologies address a significant unmet need. Please contact us to receive our informational memorandum and learn more about VisionGate’s potential.